Naloxone Hydrochloride/Oxycodone Hydrochloride Hydrate

盐酸纳洛酮/盐酸羟考酮

Report date: 2026/04/22 20:01:10

Base Information

Drug NameNaloxone Hydrochloride/Oxycodone Hydrochloride Hydrate
Drug Alias Name盐酸羟考酮水合物盐酸纳洛酮Naloxone and Oxycodone盐酸纳洛酮盐酸羟考酮oxycodone hydrochloride/naloxone hydrochlorideoxycodone hydrochloride and naloxone hydrochloride +[14] 
ClassificationSmall molecules
Mechanisms of ActionOpioid receptors agonistsOpioid receptors antagonists
TargetsOpioid receptors
Therapy Area/IndicationsConstipationChronic PainCancer Pain +[9] 
Global Approved IndicationsPainRestless Legs Syndrome
Approved Indications in ChinaPain
Original Approved Country/TerritoryGermany
Original Approved Date2006/01/01
Country/TerritoryCzechiaUnited StatesPoland +[8] 
CombinationsYes Naloxone HydrochlorideOxycodone Hydrochloride Hydrate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPurdue PharmaMundipharma Research Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesNapp Pharmaceuticals LtdShionogi & Co Ltd
Inactive CompaniesPurdue PharmaPurdue Pharma LpBard Pharmaceuticals Ltd +[6] 
Active IndicationsCancer PainPainRestless Legs Syndrome
Inactive IndicationsConstipationChronic PainLow Back Pain +[6] 

Other Information

ATC CodeN02AA55
Related LinksN/A